FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1132-1138 April 12, 2001 Number 15 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background The frequency of major malformations, growth retardation, and hypoplasia of the midface and fingers, known as anticonvulsant embryopathy, is increased in infants exposed to anticonvulsant drugs in utero. However, whether the abnormalities are caused by the maternal epilepsy itself or by exposure to anticonvulsant drugs is not known.

Methods We screened 128,049 pregnant women at delivery to identify three groups of infants: those exposed to anticonvulsant drugs, those unexposed to anticonvulsant drugs but with a maternal history of seizures, and those unexposed to anticonvulsant drugs with no maternal history of seizures (control group). The infants were examined systematically for the presence of major malformations, signs of hypoplasia of the midface and fingers, microcephaly, and small body size.

Results The combined frequency of anticonvulsant embryopathy was higher in 223 infants exposed to one anticonvulsant drug than in 508 control infants (20.6 percent vs. 8.5 percent; odds ratio, 2.8; 95 percent confidence interval, 1.1 to 9.7). The frequency was also higher in 93 infants exposed to two or more anticonvulsant drugs than in the controls (28.0 percent vs. 8.5 percent; odds ratio, 4.2; 95 percent confidence interval, 1.1 to 5.1). The 98 infants whose mothers had a history of epilepsy but took no anticonvulsant drugs during the pregnancy did not have a higher frequency of those abnormalities than the control infants.

Conclusions A distinctive pattern of physical abnormalities in infants of mothers with epilepsy is associated with the use of anticonvulsant drugs during pregnancy, rather than with epilepsy itself.

Source Information

From the Genetics and Teratology Unit, Pediatric Service, Massachusetts General Hospital (L.B.H., E.A.H., K.B.H., A.M.H.); the Department of Biostatistics, Harvard School of Public Health (B.A.C., L.M.R.); and the Department of Neurology, Brigham and Women's Hospital (S.K.) — all in Boston.

Address reprint requests to Dr. Holmes at the Genetics and Teratology Unit, Warren 801, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114-2696, or at holmes.lewis{at}mgh.harvard.edu.

Full Text of this Article

This article has been cited by other articles:

• Meador, K. J., Pennell, P. B., Harden, C. L., Gordon, J. C., Tomson, T., Kaplan, P. W., Holmes, G. L., French, J. A., Hauser, W. A., Wells, P. G., Cramer, J. A., For the HOPE Work Group, (2008). Pregnancy registries in epilepsy: A consensus statement on health outcomes. Neurology 71: 1109-1117 [Abstract] [Full Text]  
• Hunt, S., Russell, A., Smithson, W. H., Parsons, L., Robertson, I., Waddell, R., Irwin, B., Morrison, P. J., Morrow, J., Craig, J. (2008). Topiramate in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 71: 272-276 [Abstract] [Full Text]  
• Holmes, L. B., Baldwin, E. J., Smith, C. R., Habecker, E., Glassman, L., Wong, S. L., Wyszynski, D. F. (2008). Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 70: 2152-2158 [Abstract] [Full Text]  
• Williams, K. E., Marsh, W. K., Rasgon, N. L. (2007). Mood disorders and fertility in women: a critical review of the literature and implications for future research. Hum Reprod Update 13: 607-616 [Abstract] [Full Text]  
• Tomson, T., Hiilesmaa, V. (2007). Epilepsy in pregnancy. BMJ 335: 769-773 [Full Text]  
• Olfson, M., Marcus, S. (2007). Neonatal Risks of Maternal Treatment With Mood Stabilizers. Arch Gen Psychiatry 64: 866-867 [Full Text]  
• Hunt, S., Craig, J., Russell, A., Guthrie, E., Parsons, L., Robertson, I., Waddell, R., Irwin, B., Morrison, P. J., Morrow, J. (2006). Levetiracetam in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 67: 1876-1879 [Abstract] [Full Text]  
• Meador, K. J., Baker, G. A., Finnell, R. H., Kalayjian, L. A., Liporace, J. D., Loring, D. W., Mawer, G., Pennell, P. B., Smith, J. C., Wolff, M. C., for the NEAD Study Group, (2006). In utero antiepileptic drug exposure: Fetal death and malformations. Neurology 67: 407-412 [Abstract] [Full Text]  
• Jackson, M. (2006). Epilepsy in women: a practical guide to management. PN 6: 166-179 [Full Text]  
• Artama, M., Ritvanen, A., Gissler, M., Isojarvi, J., Auvinen, A. (2006). Congenital structural anomalies in offspring of women with epilepsy--a population-based cohort study in Finland. Int J Epidemiol 35: 280-287 [Abstract] [Full Text]  
• Morrow, J, Russell, A, Guthrie, E, Parsons, L, Robertson, I, Waddell, R, Irwin, B, McGivern, R C, Morrison, P J, Craig, J (2006). Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatry 77: 193-198 [Abstract] [Full Text]  
• Artama, M., Auvinen, A., Raudaskoski, T., Isojarvi, I., Isojarvi, J. (2005). Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64: 1874-1878 [Abstract] [Full Text]  
• O'Brien, M D, Gilmour-White, S K (2005). Management of epilepsy in women. Postgrad. Med. J. 81: 278-285 [Abstract] [Full Text]  
• Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., Altshuler, L. (2005). Management of Bipolar Disorder During Pregnancy The Postpartum Period. Focus 3: 266-279 [Abstract] [Full Text]  
• Cunnington, M., Tennis, P., the International Lamotrigine Pregnancy Registry S, (2005). Lamotrigine and the risk of malformations in pregnancy. Neurology 64: 955-960 [Abstract] [Full Text]  
• Wyszynski, D. F., Nambisan, M., Surve, T., Alsdorf, R. M., Smith, C. R., Holmes, L. B., for the Antiepileptic Drug Pregnancy Registry, (2005). Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64: 961-965 [Abstract] [Full Text]  
• (2005). Antiepileptics, pregnancy and the child. DTB 43: 13-16 [Abstract] [Full Text]  
• Kaplan, P. W. (2004). Reproductive health effects and teratogenicity of antiepileptic drugs. Neurology 63: S13-S23 [Abstract] [Full Text]  
• Adab, N, Kini, U, Vinten, J, Ayres, J, Baker, G, Clayton-Smith, J, Coyle, H, Fryer, A, Gorry, J, Gregg, J, Mawer, G, Nicolaides, P, Pickering, L, Tunnicliffe, L, Chadwick, D W (2004). The longer term outcome of children born to mothers with epilepsy. J. Neurol. Neurosurg. Psychiatry 75: 1575-1583 [Abstract] [Full Text]  
• Holmes, L. B., Wyszynski, D. F., Lieberman, E. (2004). The AED (Antiepileptic Drug) Pregnancy Registry: A 6-Year Experience. Arch Neurol 61: 673-678 [Abstract] [Full Text]  
• Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., Altshuler, L. (2004). Management of Bipolar Disorder During Pregnancy and the Postpartum Period. Am. J. Psychiatry 161: 608-620 [Abstract] [Full Text]  
• Costa, L. G., Steardo, L., Cuomo, V. (2004). Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects. Pharmacol. Rev. 56: 103-147 [Abstract] [Full Text]  
• LaRoche, S. M., Helmers, S. L. (2004). The New Antiepileptic Drugs: Clinical Applications. JAMA 291: 615-620 [Abstract] [Full Text]  
• Tatum, W. O. IV, Liporace, J., Benbadis, S. R., Kaplan, P. W. (2004). Updates on the Treatment of Epilepsy in Women. Arch Intern Med 164: 137-145 [Abstract] [Full Text]  
• Pennell, P. B. (2003). Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 61: S35-42 [Abstract] [Full Text]  
• Pennell, P. B. (2003). The importance of monotherapy in pregnancy. Neurology 60: S31-38 [Abstract] [Full Text]  
• Brewer, J. M., Waltman, P. A. (2003). Epilepsy and Pregnancy: Maternal and Fetal Effects of Phenytoin. Crit Care Nurse 23: 93-98 [Full Text]  
• de Jong-Potjer, L., de Bock, G., Zaadstra, B., de Jong, O., Verloove-Vanhorick, S., Springer, M. (2003). Women's interest in GP-initiated pre-conception counselling in The Netherlands. Fam Pract 20: 142-146 [Abstract] [Full Text]  
• Kaaja, E., Kaaja, R., Hiilesmaa, V. (2003). Major malformations in offspring of women with epilepsy. Neurology 60: 575-579 [Abstract] [Full Text]  
• Scher, M. S. (2003). Topical Review: Fetal and Neonatal Neurologic Case Histories: Assessment of Brain Disorders in the Context of Fetal-Maternal-Placental Disease. Part 1: Fetal Neurologic Consultations in the Context of Antepartum Events and Prenatal Brain Development. J Child Neurol 18: 85-92 [Abstract]  
• Hirschfeld, R. M.A., Bowden, C. L., Gitlin, M. J., Keck, P. E., Perlis, R. H., Suppes, T., Thase, M. E., Wagner, K. D. (2003). Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision). Focus 1: 64-110 [Full Text]  
• Bittigau, P., Sifringer, M., Genz, K., Reith, E., Pospischil, D., Govindarajalu, S., Dzietko, M., Pesditschek, S., Mai, I., Dikranian, K., Olney, J. W., Ikonomidou, C. (2002). Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc. Natl. Acad. Sci. USA 99: 15089-15094 [Abstract] [Full Text]  
• Malm, H., Kajantie, E., Kivirikko, S., Kaariainen, H., Peippo, M., Somer, M. (2002). Valproate embryopathy in three sets of siblings: Further proof of hereditary susceptibility. Neurology 59: 630-633 [Abstract] [Full Text]  
• Polifka, J. E., Friedman, J.M. (2002). Medical genetics: 1. Clinical teratology in the age of genomics. CMAJ 167: 265-273 [Abstract] [Full Text]  
• Diaz-Arrastia, R., Agostini, M. A., Van Ness, P. C. (2002). Evolving Treatment Strategies for Epilepsy. JAMA 287: 2917-2920 [Full Text]  
• Dolk, H, McElhatton, P (2002). Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medications. J. Med. Genet. 39: 243-244 [Full Text]  
• Holmes, L B (2002). The teratogenicity of anticonvulsant drugs: a progress report. J. Med. Genet. 39: 245-247 [Full Text]  
• Shorvon, S (2002). Antiepileptic drug therapy during pregnancy: the neurologist's perspective. J. Med. Genet. 39: 248-250 [Full Text]  
• (2001). Anticonvulsant Drugs and Fetal Abnormalities. JWatch Psychiatry 2001: 9-9 [Full Text]  
• (2001). Anticonvulsant Drugs Are Teratogens. JWatch Neurology 2001: 1-1 [Full Text]  
• (2001). Anticonvulsant Drugs and Fetal Abnormalities. JWatch General 2001: 4-4 [Full Text]